In 2017, Ma et al. reported three pediatric cases of JEV-induced anti-NMDAR encephalitis developing 3–4 weeks following the first presentation, all with confirmation of JEV IgM antibodies in serum and CSF (5). This evidence concerns the gene CD40LG and encephalitis.